BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16169677)

  • 1. Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation.
    Lee AW; Yau TK; Wong DH; Chan EW; Yeung RM; Ng WT; Tong M; Soong IS; Sze WM
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1331-8. PubMed ID: 16169677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma.
    Lee AW; Tung SY; Chan AT; Chappell R; Fu YT; Lu TX; Tan T; Chua DT; O'sullivan B; Xu SL; Pang ES; Sze WM; Leung TW; Kwan WH; Chan PT; Liu XF; Tan EH; Sham JS; Siu L; Lau WH
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):142-51. PubMed ID: 16904519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma.
    Lee AW; Lau KY; Hung WM; Ng WT; Lee MC; Choi CW; Chan CC; Tung R; Cheng PT; Yau TK
    Radiother Oncol; 2008 May; 87(2):204-10. PubMed ID: 18329742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma.
    Al-Amro A; Al-Rajhi N; Khafaga Y; Memon M; Al-Hebshi A; El-Enbabi A; El-Husseiny G; Radawi A; Belal A; Allam A; El-Sebaie M
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):508-13. PubMed ID: 15890594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma.
    Lee AW; Tung SY; Chua DT; Ngan RK; Chappell R; Tung R; Siu L; Ng WT; Sze WK; Au GK; Law SC; O'Sullivan B; Yau TK; Leung TW; Au JS; Sze WM; Choi CW; Fung KK; Lau JT; Lau WH
    J Natl Cancer Inst; 2010 Aug; 102(15):1188-98. PubMed ID: 20634482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group.
    Lee AW; Lau WH; Tung SY; Chua DT; Chappell R; Xu L; Siu L; Sze WM; Leung TW; Sham JS; Ngan RK; Law SC; Yau TK; Au JS; O'Sullivan B; Pang ES; O SK; Au GK; Lau JT;
    J Clin Oncol; 2005 Oct; 23(28):6966-75. PubMed ID: 16192584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
    Chua DT; Sham JS; Au GK
    Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
    Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
    Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
    Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors.
    Lee AW; Ng WT; Hung WM; Choi CW; Tung R; Ling YH; Cheng PT; Yau TK; Chang AT; Leung SK; Lee MC; Bentzen SM
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1121-8. PubMed ID: 18723296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma.
    Poon D; Yap SP; Wong ZW; Cheung YB; Leong SS; Wee J; Tan T; Fong KW; Chua ET; Tan EH
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1312-8. PubMed ID: 15275714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
    Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Min HQ
    J Clin Oncol; 2005 Feb; 23(6):1118-24. PubMed ID: 15657403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
    Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
    Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft für Pädiatrische Onkologie und Hämatologie.
    Mertens R; Granzen B; Lassay L; Gademann G; Hess CF; Heimann G
    Cancer; 1997 Sep; 80(5):951-9. PubMed ID: 9307197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma.
    Hareyama M; Sakata K; Shirato H; Nishioka T; Nishio M; Suzuki K; Saitoh A; Oouchi A; Fukuda S; Himi T
    Cancer; 2002 Apr; 94(8):2217-23. PubMed ID: 12001120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma.
    Kwong DL; Sham JS; Leung LH; Cheng AC; Ng WM; Kwong PW; Lui WM; Yau CC; Wu PM; Wei W; Au G
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):374-81. PubMed ID: 16213105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results.
    Ponzanelli A; Vigo V; Marcenaro M; Bacigalupo A; Gatteschi B; Ravetti JL; Corvò R; Benasso M
    Oral Oncol; 2008 Aug; 44(8):767-74. PubMed ID: 18061519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study.
    Ferrari D; Chiesa F; Codecà C; Calabrese L; Jereczek-Fossa BA; Alterio D; Fiore J; Luciani A; Floriani I; Orecchia R; Foa P
    Oncology; 2008; 74(3-4):158-66. PubMed ID: 18714164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of failure following radiation with and without chemotherapy in patients with nasopharyngeal carcinoma.
    Fuchs S; Rödel C; Brunner T; Iro H; Niedobitek G; Sauer R; Grabenbauer GG
    Onkologie; 2003 Feb; 26(1):12-8. PubMed ID: 12624512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.